Target intelligence / Profile preview

Pathogen and antigen targets recognized by IgG Fab

Molecular classification
Other
01

Overview

Pathogen and antigen targets recognized by IgG Fab refer to the specific molecular structures, known as epitopes, that are bound by the Fragment antigen-binding (Fab) region of Immunoglobulin G (IgG) antibodies (Schroeder & Cavacini, 2010). The Fab region is composed of one constant and one variable domain from each of the heavy and light chains, with the variable domains containing complementarity-determining regions (CDRs) that dictate specificity (Janeway et al., 2001). These targets encompass a vast array of molecules, including viral surface proteins, bacterial toxins, and tumor-associated antigens. Upon binding, the IgG molecule can neutralize the target's biological activity or facilitate its clearance through effector functions like opsonization or antibody-dependent cellular cytotoxicity (ADCC) (Forthal, 2014). In a therapeutic context, this 'target' is not a single entity but a broad category representing the diverse antigens addressed by monoclonal antibody therapies and vaccines (Lu et al., 2020). The interaction is characterized by high affinity and specificity, which are essential for the immune system to distinguish between self and non-self or healthy and diseased cells. Consequently, the term describes a functional class of interactions rather than a specific, individual therapeutic target.

Other names
AntigensEpitopesAntibody-binding sitesTarget antigensAntigenic determinants
02

Mechanism of action

The Fab region of IgG binds to specific epitopes on pathogens or diseased cells, leading to direct neutralization or the recruitment of immune effector mechanisms such as ADCC and CDC.

03

Biological functions

Immune responseAntigen recognitionNeutralizationOpsonization
04

Disease associations

InfectionCancerAutoimmune diseaseInflammation
05

Safety considerations

Off-target bindingImmunogenicityAntibody-dependent enhancement (ADE)Cytokine release syndrome
06

Interacting drugs

Monoclonal antibodies

2 more in the full profile.

Beyond the preview

Go deeper on Pathogen and antigen targets recognized by IgG Fab.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogen and antigen targets recognized by IgG Fab.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call